Isogenic Mutant Human Cells: a New Tool for Personalized Cancer Medicine
Overview
Affiliations
Plunkett C, Kumar A, Yrastorza J, Hou Y, Placone J, Grennan G Adv Healthc Mater. 2020; 9(8):e1901366.
PMID: 31951109 PMC: 7274860. DOI: 10.1002/adhm.201901366.
Hoshi H, Hiyama G, Ishikawa K, Inageda K, Fujimoto J, Wakamatsu A Oncol Rep. 2016; 37(1):66-76.
PMID: 27840973 PMC: 5355725. DOI: 10.3892/or.2016.5227.
In vitro human cell line models to predict clinical response to anticancer drugs.
Niu N, Wang L Pharmacogenomics. 2015; 16(3):273-85.
PMID: 25712190 PMC: 4358765. DOI: 10.2217/pgs.14.170.
Amphiregulin and PTEN evoke a multimodal mechanism of acquired resistance to PI3K inhibition.
Edgar K, Crocker L, Cheng E, Wagle M, Wongchenko M, Yan Y Genes Cancer. 2014; 5(3-4):113-26.
PMID: 25053989 PMC: 4091530. DOI: 10.18632/genesandcancer.10.
Advances in homology directed genetic engineering of human pluripotent and adult stem cells.
Ramamoorthi K, Curtis D, Asuri P World J Stem Cells. 2013; 5(4):98-105.
PMID: 24179598 PMC: 3812527. DOI: 10.4252/wjsc.v5.i4.98.